Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor
about
The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus FormationFactor XI and contact activation as targets for antithrombotic therapyA Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin SystemsDefective glycosylation of coagulation factor XII underlies hereditary angioedema type IIIThe polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular DiseaseNeutralizing blood-borne polyphosphate in vivo provides safe thromboprotection.Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation.The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.Potential mechanisms linking SIRT activity and hypoxic 2-hydroxyglutarate generation: no role for direct enzyme (de)acetylation.Antithrombotic potential of the contact activation pathway.The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.The Effects of the Contact Activation System on Hemorrhage.Krüppel-like factors and vascular wall homeostasis.Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.Plasma Prekallikrein: Its Role in Hereditary Angioedema and Health and Disease.
P2860
Q26775616-67343192-EAB7-4151-AFD9-7D243F4B0906Q26786677-7F525467-6768-49BC-9E94-C5B76F684C80Q27024190-04B07154-EE48-46CE-A993-7F162B88969CQ28069799-A9E65006-2DCF-457C-A627-CEEB7B5DBB2CQ35700453-10348176-3229-4233-80B4-C6B6E7A945C5Q36051099-8BE9A4B4-DA04-45D6-93B5-2CA39DD72DA2Q36268944-4CD23CAF-B3D9-4E8B-A6F8-13EE0C657AFEQ36562533-B5916B95-2673-440F-AD7B-76E5CE8103FEQ36767718-73975CB7-3D69-4CEB-80C1-B0A87FCAAB6EQ36849706-56961772-00D4-4672-A8B8-F8A21AB5CF38Q37261059-FB010032-E0A6-4B29-8E52-1EAC73926D4EQ37660657-13B7F8CD-B662-49E9-8A2E-FD6A82B6E1E6Q38632499-883EAB64-82D9-40C1-9BF5-D0C14063460EQ38695413-CBF171B6-1CCB-4087-AB0C-810D8D92D96DQ38886826-30DF942F-D1DA-47A8-8A11-5E1B0E8BF718Q38956551-9E184C86-CE9F-4ECC-AC41-2FC029B41215Q41171782-2EB611C9-B3B0-4D62-96BA-2DC5B9676F99Q47676828-E41BDAD7-BD84-4AD6-AE61-DEDF09D90456Q47720411-5419FCE0-A057-485C-AFC6-2C81775BE951Q49272297-8DBB6ACA-197E-45F8-9814-85B6427C8EAA
P2860
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@ast
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@en
type
label
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@ast
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@en
prefLabel
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@ast
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@en
P2093
P2860
P1433
P1476
Reduced thrombosis in Klkb1-/- ...... F4 and decreased tissue factor
@en
P2093
Alona Merkulova
Alvin H Schmaier
Nadja Grobe
Nigel Mackman
Omar Alhalabi
P2860
P304
P356
10.1182/BLOOD-2014-01-550285
P407
P577
2014-10-22T00:00:00Z